Francois Bertelli

Title: Inventor Spotlight: Francois Bertelli

Introduction

Francois Bertelli is an innovative inventor based in Epalinges, Switzerland. He has made significant contributions to the field of biotechnology, particularly with his work involving antibodies. His expertise has led to the development of a groundbreaking patent that addresses critical health challenges.

Latest Patents

Francois holds a patent for Anti-IL13Rα2 antibodies. This invention relates to antibodies that specifically bind to the Interleukin-13 receptor subunit alpha-2 (IL13Rα2) protein. The patent outlines various associated uses and methods for production, showcasing the potential impact of his work in therapeutic applications.

Career Highlights

Currently, Francois is employed at Adc Therapeutics SA, where he continues to advance research and development in antibody therapies. His role at the company emphasizes his commitment to innovating solutions in the biotech sector, especially in the treatment of diseases where IL13Rα2 plays a pivotal role.

Collaborations

Francois works alongside a talented coworker, Patricius Hendrikus Cornelis Van Berkel. Their collaboration highlights the importance of teamwork in scientific research, enhancing the potential for innovative discoveries and applications in biotechnology.

Conclusion

Francois Bertelli embodies the spirit of innovation in the field of biotechnology. His patent for Anti-IL13Rα2 antibodies reflects his dedication to addressing important health issues, while his ongoing work at Adc Therapeutics SA underlines the collaborative efforts that drive advancements in medical science. As a leading inventor, Francois continues to pave the way for future breakthroughs in antibody therapies.